Abstract
Influenza experts have been trying for a long time to convince other scientists, the public health community, and the general population that preparations for a pandemic should be a priority. But it was not until the highly pathogenic H5N1 avian strain emerged, causing a great epizootic and infecting and killing people exposed to infected birds, that research on this topic exploded. Below I discuss some truly phenomenal advances that have emerged from this newfound interest in pandemic influenza, to show that, yes, we are doing enough.
MeSH terms
-
Adamantane / pharmacology
-
Adamantane / supply & distribution
-
Adjuvants, Immunologic / pharmacology
-
Animals
-
Antiviral Agents / pharmacology
-
Antiviral Agents / supply & distribution
-
Disease Outbreaks* / history
-
Drug Approval
-
Drug Design
-
Drug Resistance, Viral
-
Enzyme Inhibitors / pharmacology
-
Enzyme Inhibitors / supply & distribution
-
History, 20th Century
-
Humans
-
Influenza A Virus, H1N1 Subtype / immunology
-
Influenza A Virus, H5N1 Subtype / immunology*
-
Influenza Vaccines* / history
-
Influenza Vaccines* / pharmacology
-
Influenza Vaccines* / supply & distribution
-
Influenza in Birds / epidemiology
-
Influenza in Birds / prevention & control
-
Influenza, Human / epidemiology*
-
Influenza, Human / history
-
Influenza, Human / prevention & control*
-
Influenza, Human / virology
-
Neuraminidase / antagonists & inhibitors
-
Oseltamivir / pharmacology
-
Oseltamivir / supply & distribution
-
Poultry / virology
-
United States
-
United States Food and Drug Administration
Substances
-
Adjuvants, Immunologic
-
Antiviral Agents
-
Enzyme Inhibitors
-
Influenza Vaccines
-
Oseltamivir
-
Neuraminidase
-
Adamantane